212 related articles for article (PubMed ID: 20707291)
1. Decline in FEV1 related to genetic polymorphisms (+138insA/delA and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study.
Kaparianos A; Argyropoulou E; Efremidis G; Flordellis C; Spiropoulos K
Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):705-19. PubMed ID: 20707291
[TBL] [Abstract][Full Text] [Related]
2. Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control study.
Kaparianos A; Argyropoulou E; Efremidis G; Spiropoulos K
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1149-57. PubMed ID: 22165675
[TBL] [Abstract][Full Text] [Related]
3. Positive association between two polymorphic sites (+134 insA/delA and G198T) of the endothelin-1 gene and chronic obstructive pulmonary disease. A case-control study.
Sampsonas F; Antonacopoulou A; Spathas D; Lykouras D; Kalofonos H; Flordellis C; Spiropoulos K; Siafakas N
Respir Med; 2010 Jan; 104(1):114-20. PubMed ID: 19640695
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
[TBL] [Abstract][Full Text] [Related]
5. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between glutathione S-transferase P1 polymorphism and COPD in Koreans.
Yim JJ; Yoo CG; Lee CT; Kim YW; Han SK; Shim YS
Lung; 2002; 180(2):119-25. PubMed ID: 12172904
[TBL] [Abstract][Full Text] [Related]
7. Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers.
Seo T; Pahwa P; McDuffie HH; Yurube K; Egoshi M; Umemoto Y; Ghosh S; Fukushima Y; Nakagawa K
Pharmacogenet Genomics; 2008 Jun; 18(6):487-93. PubMed ID: 18496128
[TBL] [Abstract][Full Text] [Related]
8. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
9. Il13 promoter (-1055) polymorphisms associated with chronic obstructive pulmonary disease in Taiwanese.
Liu SF; Chen YC; Wang CC; Fang WF; Chin CH; Su MC; Lin MC
Exp Lung Res; 2009 Dec; 35(10):807-16. PubMed ID: 19995275
[TBL] [Abstract][Full Text] [Related]
10. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
Yang SF; Xu YJ; Xie JG; Zhang ZX
Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
[TBL] [Abstract][Full Text] [Related]
11. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease.
Xiao D; Wang C; Du MJ; Pang BS; Zhang HY; Xiao B; Liu JZ; Weng XZ; Su L; Christiani DC
Chin Med J (Engl); 2004 May; 117(5):661-7. PubMed ID: 15161530
[TBL] [Abstract][Full Text] [Related]
12. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 polymorphisms involved in impaired exercise tolerance in COPD patients. A pilot study.
Sampsonas E; Lykouras D; Drakatos P; Moschopoulou A; Spiropoulos K; Karkoulias K
Eur Rev Med Pharmacol Sci; 2011 Feb; 15(2):123-8. PubMed ID: 21434478
[TBL] [Abstract][Full Text] [Related]
14. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing.
Jiang L; He B; Zhao MW; Ning LD; Li XY; Yao WZ
Chin Med J (Engl); 2005 Apr; 118(7):541-7. PubMed ID: 15820084
[TBL] [Abstract][Full Text] [Related]
15. Increased intraepithelial T-cells in stable COPD.
Löfdahl MJ; Roos-Engstrand E; Pourazar J; Bucht A; Dahlen B; Elmberger G; Blomberg A; Sköld CM
Respir Med; 2008 Dec; 102(12):1812-8. PubMed ID: 18706796
[TBL] [Abstract][Full Text] [Related]
16. The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly Japanese.
Kai S; Nomura A; Morishima Y; Ishii Y; Sakamoto T; Hegab AE; Sekizawa K
Arch Gerontol Geriatr; 2006; 42(2):117-24. PubMed ID: 16125804
[TBL] [Abstract][Full Text] [Related]
17. Productive cough is an independent risk factor for the development of COPD in former smokers.
Yamane T; Hattori N; Kitahara Y; Haruta Y; Sasaki H; Yokoyama A; Kohno N
Respirology; 2010 Feb; 15(2):313-8. PubMed ID: 20070589
[TBL] [Abstract][Full Text] [Related]
18. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology.
Gosman MM; Boezen HM; van Diemen CC; Snoeck-Stroband JB; Lapperre TS; Hiemstra PS; Ten Hacken NH; Stolk J; Postma DS
Thorax; 2007 Mar; 62(3):242-7. PubMed ID: 17090574
[TBL] [Abstract][Full Text] [Related]
19. Association of dopamine-related gene alleles, smoking behavior and decline in FEV1 in subjects with COPD: findings from the lung health study.
Tashkin DP; Rabinoff M; Noble EP; Ritchie TL; Simmons MS; Connett J
COPD; 2012 Dec; 9(6):620-8. PubMed ID: 22958175
[TBL] [Abstract][Full Text] [Related]
20. Intronic single-nucleotide polymorphisms in Bcl-2 are associated with chronic obstructive pulmonary disease severity.
Sata M; Takabatake N; Inoue S; Shibata Y; Abe S; Machiya J; Wada T; Ji G; Kido T; Matsuura T; Muramatsu MA; Kubota I
Respirology; 2007 Jan; 12(1):34-41. PubMed ID: 17207023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
